The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some pharmaceutical industry leaders that the firm is particularly bullish on. CLICK HERE.
The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some pharmaceutical industry leaders that the firm is particularly bullish on. CLICK HERE.